Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation
Kirsten Herbert, Andrew Spencer, Andrew Grigg, et al.
Bone Marrow Transplantation (2004) Vol. 34, Iss. 6, pp. 521-525
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Graft-versus-leukemia effects of transplantation and donor lymphocytes
Hans‐Jochem Kolb
Blood (2008) Vol. 112, Iss. 12, pp. 4371-4383
Open Access | Times Cited: 567
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Steven Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 205.e1-205.e16
Closed Access | Times Cited: 352
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Sarah McCue Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 223.e1-223.e17
Closed Access | Times Cited: 326
How I treat mycosis fungoides and Sézary syndrome
Sean Whittaker, Richard T. Hoppe, H. Miles Prince
Blood (2016) Vol. 127, Iss. 25, pp. 3142-3153
Open Access | Times Cited: 229
Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy
Charlotte FM Hughes, Amit Khot, Christopher McCormack, et al.
Blood (2014) Vol. 125, Iss. 1, pp. 71-81
Open Access | Times Cited: 200
Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Celso Arrais‐Rodrigues, Guillermo Sanz, Claudio G. Brunstein, et al.
Journal of Clinical Oncology (2008) Vol. 27, Iss. 2, pp. 256-263
Closed Access | Times Cited: 205
Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Rafael F. Duarte, Carmen Canals, Francesco Onida, et al.
Journal of Clinical Oncology (2010) Vol. 28, Iss. 29, pp. 4492-4499
Open Access | Times Cited: 195
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
Elise A. Olsen, Alain H. Rook, John A. Zic, et al.
Journal of the American Academy of Dermatology (2010) Vol. 64, Iss. 2, pp. 352-404
Closed Access | Times Cited: 161
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018
D. Gilson, Sean Whittaker, Fiona Child, et al.
British Journal of Dermatology (2018) Vol. 180, Iss. 3, pp. 496-526
Closed Access | Times Cited: 131
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome
Mary Jo Lechowicz, Hillard M. Lazarus, Joaquim Carreras, et al.
Bone Marrow Transplantation (2014) Vol. 49, Iss. 11, pp. 1360-1365
Open Access | Times Cited: 95
How I treat mycosis fungoides and Sézary syndrome
H. Miles Prince, Sean Whittaker, Richard T. Hoppe
Blood (2009) Vol. 114, Iss. 20, pp. 4337-4353
Open Access | Times Cited: 127
Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma
Rafael F. Duarte, Norbert Schmitz, Octavio Servitje, et al.
Bone Marrow Transplantation (2008) Vol. 41, Iss. 7, pp. 597-604
Closed Access | Times Cited: 124
A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome
Peggy A. Wu, Youn H. Kim, Phillip W. Lavori, et al.
Biology of Blood and Marrow Transplantation (2009) Vol. 15, Iss. 8, pp. 982-990
Open Access | Times Cited: 111
Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma
Frederick Lansigan, Francine M. Foss
Drugs (2010) Vol. 70, Iss. 3, pp. 273-286
Closed Access | Times Cited: 98
Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas
Adèle de Masson, M. Beylot‐Barry, Jean‐David Bouaziz, et al.
Haematologica (2013) Vol. 99, Iss. 3, pp. 527-534
Open Access | Times Cited: 79
Cord Blood Hematopoietic Cell Transplantation
Hal E. Broxmeyer, Sherif Farag, Vanderson Rocha
(2015), pp. 437-455
Closed Access | Times Cited: 77
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study
Sylvia Feyler, H. Miles Prince, Rachel Pearce, et al.
Bone Marrow Transplantation (2007) Vol. 40, Iss. 5, pp. 443-450
Closed Access | Times Cited: 100
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma
Sean Whittaker, Francine M. Foss
Cancer Treatment Reviews (2007) Vol. 33, Iss. 2, pp. 146-160
Open Access | Times Cited: 91
Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience
Hidehiro Itonaga, Hideki Tsushima, Jun Taguchi, et al.
Blood (2012) Vol. 121, Iss. 1, pp. 219-225
Closed Access | Times Cited: 67
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Eva Domingo‐Domènech, Rafael F. Duarte, Ariane Boumedil, et al.
Bone Marrow Transplantation (2021) Vol. 56, Iss. 6, pp. 1391-1401
Closed Access | Times Cited: 35
Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome
Pooja Virmani, Jasmine Zain, Steven T. Rosen, et al.
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 807-818
Open Access | Times Cited: 44
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant
Jeffrey L. Goldberg, Joanne F. Chou, Steven M. Horwitz, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2011) Vol. 53, Iss. 6, pp. 1124-1129
Open Access | Times Cited: 40
Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma
Koichiro Yuji, Shigesaburo Miyakoshi, Daisuke Kato, et al.
Biology of Blood and Marrow Transplantation (2005) Vol. 11, Iss. 4, pp. 314-318
Open Access | Times Cited: 56
Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma
Elisabetta Capriotti, Eric C. Vonderheid, Christopher J. Thoburn, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2008) Vol. 49, Iss. 6, pp. 1190-1201
Open Access | Times Cited: 47
Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation
Kentaro Yonekura, Atae Utsunomiya, Y Takatsuka, et al.
Bone Marrow Transplantation (2008) Vol. 41, Iss. 12, pp. 1029-1035
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top